Unlearn.AI named to the 2021 CB Insights AI 100 List of Most Innovative Artificial Intelligence Startups

The AI 100 is CB Insights' annual list of the 100 most promising private AI companies in the world. This year’s winners are working on solutions including AI transparency, climate risk, virus modeling, and more.

CB Insights has unveiled the winners of the fifth annual AI 100. This year’s cohort of promising private AI companies represents 12 countries and is driving innovation across 18 industries and a broad range of cross-industry applications.

The products that this year’s winners are bringing to market — from drug R&D and revenue cycle management for hospitals to autonomous beekeeping and municipal waste sortation — highlight the breadth and depth of AI’s impact on industries.

Using the CB Insights platform, our research team picked these 100 private market vendors from a pool of over 6K companies, including applicants and nominees. They were chosen based on factors including business relations, investor profile, news sentiment analysis, R&D activity, proprietary Mosaic scores, market potential, competitive landscape, team strength, and tech novelty.

Enter your email address to download paper.

Click the link to begin download.
Oops! Something went wrong while submitting the form.
Blog

Welcoming Dr. Taylor to Unlearn.AI’s Board of Directors

Press

Unlearn Appoints AstraZeneca’s Chief Medical Officer Ann E. Taylor, M.D. to Board of Directors

Blog

AD/PD 2021: Unlearn will present novel, AI-driven approaches to enabling smaller, more efficient Alzheimer’s clinical trials

Join us at The 15th​ International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders, March 9 - 14, 2021.
Ann E. Taylor, M.D., Chief Medical Officer at AstraZeneca, has joined the Unlearn Board of Directors.
I’m honored to have such an inspirational and experienced leader like Dr. Taylor join our board.